3 ms·

I was interested to find out what the “moonshot” was... it was making dogs live longer. I like dogs, but...

• rokobobo 5y ago
  My understanding is that dog-related food/medicine/nutritional supplements have a lot lower bar than human-grade equivalents, when it comes to regulatory clearance. On one hand, that makes me very skeptical that this would actually be more than a snake oil in its first 5 years of existence. On the other hand, I imagine that this could be an interesting "proving ground" for potential human-grade longevity solutions. I think that's the real moonshot.
• walterbell 5y ago
  If they can help dogs to live longer, which animal could be next? https://www.celinehh.com/aging-field https://www.celinehh.com/aging-field > The reasons we do not have an approved aging drug today are not due to the science - the biological blockers to a first-generation aging drug have been clear for at least ten years. The primary reasons there are no approved aging drugs today are much more tricky - they are regulatory, societal, structural, and cultural. > For the last years, I’ve been a researcher in academic aging labs, worked in aging-focused venture capital and early-stage aging drug development startups, and am now the founder of the aging biotech Loyal. The common theme of my work has been trying to find the highest leverage way to support and accelerate the first aging drug approval.